OakChart

QT Imaging Holdings Inc

QTIHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:59 PM ET

2.12-0.14 (-6.19%)
2026-11-12 03:45 CET
Market cap
31.03 USD m
Revenue, TTM
29.58 USD m
Net income, TTM
-16.16 USD m
Free cash flow, TTM
-14.12 USD m
EPS diluted, TTM
-1.11
P/E
-
Compare

Price

QTI against its 20, 50 and 200-day averages
2050200earnings
2.004.006.00197K395KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26QTIclose 2.1220-day 2.2450-day 2.46200-day 4.332.1252w high

72.1% under the 52-week high of 7.60 on 12 May 2026. 52-week low 1.96 on 11 Nov 2026. Last 15 sessions, 24.5% high to low

Volume 2.20× normal · the line is the 50-bar volume average

Profile

QTI
52-week range, 2% of the way up
2.017.60

QT Imaging Holdings, Inc. is a medical device company, which engages in the research, development, and commercialization of body imaging systems using low energy sound. The company was founded by Avi S. Katz and Raluca Dinu on January 19, 2021 and is headquartered in Novato, CA.

Employees32
IPONov 04, 2021
Beta0.03
ATR, 14d0.19
Rel volume2.20
Short float1.84%
Insider own21.76%
Inst own22.29%

Snapshot

6 groups

Valuation

Index-
Market Cap31.03M
Enterprise Value39.35M
Income-16.16M
Sales29.58M
Book/sh0.18
Cash/sh0.58
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees32
IPONov 04, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S1.05
P/B11.74
P/C3.69
P/FCF-
EV/EBITDA-
EV/Sales1.33
Quick Ratio1.65
Current Ratio2.78
Debt/Eq6.32
LT Debt/Eq6.11
Option/ShortNo / Yes

Earnings

EPS (ttm)-1.11
EPS next Y-0.15
EPS next Q0.02
EPS this Y52.28%
EPS next Y84.45%
EPS next 5Y-
EPS past 3/5Y-61.26% -105.48%
Sales past 3/5Y- -
EPS Y/Y TTM46.67%
Sales Y/Y TTM157.30%
EPS Q/Q96.06%
Sales Q/Q75.09%
EarningsNov 10 AMC
EPS/Sales Surpr.77.14% -31.98%

Ownership

Insider Own21.76%
Insider Trans0.00%
Inst Own22.29%
Inst Trans12.67%
ROA-75.80%
ROE-2125.24%
ROIC-85.74%
Gross Margin40.24%
Oper. Margin-24.89%
Profit Margin-54.63%
SMA20-5.43%
SMA50-13.67%
SMA200-51.03%
Trades-

Technical

Shs Outstand14.67M
Shs Float11.45M
Short Float1.84%
Short Ratio6.03
Short Interest0.21M
52W High7.60 -72.11%
52W Low2.01 5.47%
Volatility9.21% 7.45%
ATR (14)0.19
RSI (14)39.76
Beta0.03
Rel Volume2.20
Avg Volume34.96K
Volume76,803

Performance

Perf Week-3.20%
Perf Month-13.47%
Perf Quarter-25.61%
Perf Half Y-66.46%
Perf YTD-65.25%
Perf Year-66.13%
Perf 3Y-93.50%
Perf 5Y-92.86%
Perf 10Y-
Recom1.00
Target Price9.75
Prev Close2.26
Price2.12
Change %-6.19%

Peers

Mkt cap
TickerCompanyMkt cap
HYPRHyperfine Inc75.43M
NNOXNano X Imaging Ltd28.66M
BFLYButterfly Network Inc1.91B
PLSMPulsenmore Ltd12.43M
VREXVarex Imaging Corp780.90M
NDRAENDRA Life Sciences Inc7.15M
CVCapsoVision Inc333.63M
LMRILumexa Imaging Holdings Inc1.53B
RDNTRadnet Inc6.15B
HTFLHeartflow Inc5.14B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Weiner ZeevDirectorMar 17 '26Option Exercise2.0923,05448,21751,593Mar 24 09:42 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 90
  • QT Imaging Wins Medicare Payment But Cuts 2026 Revenue Outlook As Gulf Shipments Stall And Cash Runway Shrinks (Earnings Whispers) -6.19%
  • QT Imaging Reports 75% Third Quarter Revenue Growth and Major Medicare Reimbursement Milestone (Business Wire)
  • QT Imaging Secures First GCC Commercial Order from American Hospital Dubai, Plans Clinical Research Collaboration (Business Wire)
  • QT Imaging Secures Medicare Outpatient Reimbursement for QTscan, Effective January 2027 (Business Wire) +12.81%
  • QT Imaging to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) -5.48%
  • QT Imaging's Unchanged $39 Million Target Faces A Steep Second-Half Math Test (Earnings Whispers)
  • QT Imaging to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026 (Business Wire)
  • QT Imaging's Breast Acoustic CT Scanner Now Available Through National Group Purchasing Agreement with Premier (Business Wire)
  • QT Imaging Announces CPT Category III Code for 3D Breast Acoustic Imaging Now Effective (Business Wire)
  • QT Imaging to Ring the Nasdaq Closing Bell on October 2 in Recognition of Breast Cancer Awareness Month (Business Wire) +5.31%
  • QT Imaging to be Honored at Premier's Annual Supplier Innovation Celebration (Business Wire)
  • QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer (Business Wire)
  • QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference (Business Wire)
  • iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 (ACCESSWIRE) +5.30%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.020-0.088-0.0197.3410.794
2026Q22026-08-12-0.750-0.220-0.7467.447.602
2026Q12026-05-13-0.250-0.135-0.2476.536.452
2025Q42026-02-18-0.100-0.115-0.1028.287.752
2025Q32025-11-10-0.470-0.030-0.4754.195.351
2025Q22025-08-07---0.4233.66--
2025Q12025-05-13---1.2142.80--
2024Q42025-03-31--0.0230.85--
2024Q32024-11-13---0.5060.96--
2024Q22024-08-08---0.9001.71--
2024Q12024-05-10---0.9751.36--
2026Q4--0.016--13.344
2027Q1---0.092--10.384
2027Q2---0.061--11.354
2027Q3---0.039--12.424
2027Q4--0.033--15.444

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY-2.130--2.1284.88-
2025FY-2.010-1.615-18.9318.35
2026FY--0.959--36.66
2027FY--0.149--49.56
2028FY-0.223--58.46
2029FY-0.650--72.89
2030FY-0.980--90.47

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1140213.3412.1814.10
2026Q4S2026-11-1040014.2813.7415.28
2026Q4S2026-10-2740014.2813.7415.28
2026Q4S2026-10-2240214.2813.7415.28
2026Q4S2026-10-0230214.3713.7415.28
2026Q4S2026-08-1320213.9213.7414.10
2026Q4S2026-08-0420014.2014.1014.30
2026Q4S2026-08-0121014.2014.1014.30
2026Q4S2026-06-0222014.2014.1014.30
2026Q4S2026-05-2122014.1814.0714.30
2026Q4S2026-05-1822013.3612.4114.30
2026Q4S2026-05-1321012.2612.1012.41
2026Q4S2026-03-2621012.2612.1012.41
2026Q4S2026-02-2021012.1512.1012.20

Estimate history

EPS, annual-0.113-0.48-1.918-2.128-2.013-1.1141
Period20212022202320242025TTM
EPS, quarterly-0.5060.023-1.214-0.423-0.475-0.102-0.247-0.746-0.019
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual000.044.87918.92529.58
Period20212022202320242025TTM
Sales, quarterly0.9560.8462.7983.6594.1928.2756.537.4357.34
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual9.8483.523.1928.92311.90214.671
Period20212022202320242025MRQ
Shares, quarterly7.1478.9239.2189.5489.66711.90212.04213.76914.671
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Total Revenue29.5818.934.880.040.000.00
Cost of Goods Sold Incl. D&A17.6810.342.330.620.000.00
Gross Profit11.908.582.55-0.580.000.00
Selling, General and Administrative Excl. Other19.2613.0214.734.434.281.08
Research and Development6.323.943.181.30--
Other Operating Expense0.000.000.000.000.000.00
Operating Income-7.36-4.44-12.18-5.01-4.28-1.08
Interest Expense3.012.644.500.540.02-
Unusual Expense5.795.25-7.650.00-0.380.03
Net Income Before Taxes-16.16-21.08-9.00-6.10-2.29-1.11
Income Taxes-0.00-0.00-0.020.000.490.00
Consolidated Net Income-16.16-21.08-8.98-6.10-3.92-1.11
Net Income From Continuing Operations-16.16-21.08-8.98-6.10-3.92-1.11
Net Income-16.16-21.08-14.17-6.10-3.92-1.11
EPS (Recurring)-0.76-1.66-2.93-1.92-0.51-0.11
EPS (Basic, Before Extraordinaries)-1.11-2.01-2.13-1.92-0.48-0.11
EPS (Diluted)-1.11-2.01-2.13-1.92-0.48-0.11
EBITDA-7.25-4.31-11.95-4.53-4.28-1.08
Non-Operating Income (Expense)0.00-8.760.02-0.541.630.01
Other After Tax Adjustments0.000.000.000.00-1.14-0.00
Stock Option Compensation Expense1.710.630.230.560.08-
Price To Sales Ratio-3.382.002,734.05--
Gross Margin40.2445.3652.26-1,425.66--
Operating Margin-24.89-23.45-249.60-12,409.76--
Net Margin-54.63-111.40-290.46-15,113.25--
Shares Outstanding14.6711.908.923.193.529.85
Market Capitalization31.0331.0313.0695.17107.70292.20

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue7.347.436.538.284.193.662.800.85
Cost of Goods Sold Incl. D&A4.314.383.865.132.391.830.990.45
Gross Profit3.033.062.673.141.801.831.810.40
Selling, General and Administrative Excl. Other5.484.925.023.843.452.872.852.45
Research and Development1.721.621.721.240.940.900.850.77
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.45-1.86-2.35-0.70-1.65-1.04-1.04-2.05
Interest Expense0.330.740.931.000.560.380.691.35
Unusual Expense-2.488.460.12-0.302.312.590.65-3.55
Net Income Before Taxes-0.30-11.07-3.41-1.39-4.56-4.00-11.140.17
Income Taxes0.000.000.00-0.000.000.000.00-0.02
Consolidated Net Income-0.30-11.07-3.41-1.39-4.56-4.00-11.140.18
Net Income From Continuing Operations-0.30-11.07-3.41-1.39-4.56-4.00-11.140.18
Net Income-0.30-11.07-3.41-1.39-4.56-4.00-11.140.18
EPS (Recurring)-0.13-0.35-0.24-0.12-0.31-0.23-1.16-0.29
EPS (Basic, Before Extraordinaries)-0.02-0.75-0.25-0.10-0.47-0.42-1.210.02
EPS (Diluted)-0.02-0.75-0.25-0.10-0.47-0.42-1.210.02
EBITDA-2.39-1.84-2.33-0.68-1.61-1.00-1.00-2.02
Non-Operating Income (Expense)-0.00-0.00-0.000.01-0.030.01-8.750.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.580.530.380.220.200.170.100.06
Price To Sales Ratio-2.283.574.385.934.572.612.38
Gross Margin41.2741.1640.9237.9743.0049.9364.7547.24
Operating Margin-33.35-25.07-35.97-8.46-39.41-28.50-37.23-242.30
Net Margin-4.05-148.89-52.16-16.76-108.71-109.35-397.9421.51
Shares Outstanding14.6713.7712.0411.909.679.559.228.92
Market Capitalization31.0356.0470.6972.6068.5838.1716.5913.06

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments10.461.190.180.080.42
Short Term Receivables5.900.080.160.000.00
Inventories5.033.144.420.000.00
Other Current Assets0.700.510.050.170.74
Total Current Assets22.094.924.820.251.16
Net Property, Plant & Equipment0.891.131.760.000.00
Total Investments and Advances0.000.000.0041.69232.31
Intangible Assets-0.000.090.00-
Other Assets0.040.040.040.000.17
Total Assets23.026.096.7141.95233.63
Short Term Debt Incl. Current Port. of LT Debt0.465.395.271.640.07
Accounts Payable3.580.801.360.000.00
Other Current Liabilities3.833.600.722.540.56
Total Current Liabilities7.879.797.344.190.63
Long Term Debt4.784.514.300.000.00
Provision for Risks Charges0.000.000.000.000.00
Other Liabilities3.931.320.389.239.61
Total Liabilities16.5815.6212.0213.4210.25
Non-Equity Reserves0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00
Common Equity6.45-9.54-5.3128.53223.39
Total Shareholders Equity6.45-9.54-5.3128.53223.39
Accumulated Minority Interest0.000.000.000.000.00
Total Equity6.45-9.54-5.3128.53223.39
Total Liabilities & Stockholders Equity23.026.096.7141.95233.63
Book Value Per Share0.54-1.07-1.668.1122.68
Tangible Book Value Per Share0.54-1.07-1.698.1122.68
Full-Time Employees32213--
Price to Book Ratio11.74-1.378.333.611.31
Return on Assets-144.86-60.94-25.07-2.84-
Return on Equity--1,536.16-52.54-3.11-
Return on Invested Capital-187.81---13.73-0.50
Quick Ratio2.170.180.050.061.83
Current Ratio2.810.500.660.061.83

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Net Income-16.16-21.08-8.98-6.10-2.77-1.11
Depreciation0.110.130.230.48--
Other Funds (Non Cash)9.3615.970.101.31-2.000.12
Funds from Operations-6.69-4.98-8.65-4.31-4.77-0.99
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-7.09-3.98-1.381.662.80-0.45
Cash from Operating Activities-13.78-8.96-10.03-2.65-1.97-1.44
Capital Expenditures-0.34-0.12-0.09-0.010.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.00192.24-232.30
Purchase of Investments0.000.000.000.00-0.64-232.30
Sale Or Maturity of Investments0.000.000.000.00192.88-
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.34-0.12-0.09-0.01192.24-232.30
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock25.9213.201.501.02-192.22234.09
Repurchase of Common Pref Stock0.00-5.000.000.00-192.140.00
Sale of Common Pref Stock25.9218.201.501.02-0.09234.09
Proceedsfrom Stock Options25.6517.571.501.02-0.09234.09
Issuance or Reduction of Debt, Net-5.025.158.391.381.610.07
Change in Long Term Debt-5.025.158.391.380.000.00
Issuance of Long Term Debt0.0114.8610.471.500.000.00
Reduction of Long Term Debt-5.02-9.70-2.08-0.130.000.00
Net Financing Active Other Cash Flow-0.090.001.24-0.020.000.00
Other Financing Activities Uses-0.090.000.00-0.020.000.00
Cash from Financing Activities20.8118.3511.132.37-190.61234.16
Net Change in Cash6.699.271.01-0.29-0.340.42
Free Cash Flow-14.12-9.08-10.12-2.66-1.97-1.44
Preferred Dividends (Cash Flow)-0.00-0.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments8.4210.976.9510.461.742.04
Short Term Receivables7.437.546.385.903.273.65
Inventories11.489.876.835.035.243.23
Other Current Assets0.871.041.040.700.791.74
Total Current Assets28.2029.4221.2022.0911.0410.67
Net Property, Plant & Equipment2.271.170.790.890.790.92
Total Investments and Advances0.000.000.000.000.000.00
Other Assets0.040.040.040.040.290.04
Total Assets30.5230.6322.0323.0212.1211.63
Short Term Debt Incl. Current Port. of LT Debt0.540.440.470.465.460.47
Accounts Payable3.683.012.933.582.021.60
Other Current Liabilities5.946.055.133.835.264.24
Total Current Liabilities10.169.508.537.8712.746.31
Long Term Debt16.2015.295.344.784.494.36
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities1.513.594.373.933.971.29
Total Liabilities27.8728.3818.2316.5821.2011.96
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2.652.253.806.45-9.08-0.32
Total Shareholders Equity2.652.253.806.45-9.08-0.32
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity2.652.253.806.45-9.08-0.32
Total Liabilities & Stockholders Equity30.5230.6322.0323.0212.1211.63
Book Value Per Share0.180.160.320.54-0.94-0.03
Tangible Book Value Per Share0.180.160.320.54-0.94-0.03
Full-Time Employees---32--
Price to Book Ratio11.7412.9010.84-6.50-7.56-117.68
Return on Assets-75.80-96.64-81.18-144.85-204.52-165.76
Return on Equity--2,125.24----
Return on Invested Capital-1.58-63.12-37.28-12.36--99.21
Quick Ratio1.652.061.692.170.451.18
Current Ratio2.783.102.492.810.871.69

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.30-11.07-3.41-1.39-4.56-4.00
Depreciation0.060.020.020.020.040.04
Other Funds (Non Cash)-1.749.551.170.382.742.87
Funds from Operations-1.98-1.49-2.22-1.00-1.77-1.10
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.21-3.34-1.44-2.110.89-0.35
Cash from Operating Activities-2.19-4.84-3.65-3.10-0.88-1.44
Capital Expenditures-0.07-0.17-0.02-0.080.00-0.05
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.07-0.17-0.02-0.080.00-0.05
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.268.870.4016.91-4.410.70
Repurchase of Common Pref Stock0.000.000.000.00-5.000.00
Sale of Common Pref Stock-0.268.870.4016.910.590.70
Proceedsfrom Stock Options-0.269.020.0016.890.680.00
Issuance or Reduction of Debt, Net0.000.00-0.01-5.014.99-0.18
Change in Long Term Debt0.000.00-0.01-5.014.99-0.18
Issuance of Long Term Debt0.000.000.000.015.00-0.15
Reduction of Long Term Debt0.000.00-0.01-5.01-0.01-0.03
Net Financing Active Other Cash Flow-0.030.17-0.230.000.000.00
Other Financing Activities Uses-0.030.17-0.230.000.000.00
Cash from Financing Activities-0.299.040.1611.910.570.52
Net Change in Cash-2.554.02-3.518.73-0.31-0.97
Free Cash Flow-2.26-5.01-3.67-3.18-0.88-1.49

Revenue breakdown

Product2024: 4.68M 2025: 18.75M
Service2024: 199.00K 2025: 175.00K
Non-US2024: 55.00K 2025: 42.00K
United States2024: 4.82M 2025: 18.88M
Consolidation, Policy2024: 335
Reportable2024: 4.88M
Total Electromedical & Electrotherapeutic Apparatus revenue2025: 18.93M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.84%0.2M11.5M31.76K
2026-10-151.66%0.2M11.5M37.08K
2026-09-302.27%0.3M11.5M33.32K
2026-09-152.05%0.2M11.5M35.40K
2026-08-312.38%0.3M11.3M40.79K
2026-08-141.89%0.2M11.8M49.96K
2026-07-311.91%0.2M11.1M56.41K
2026-07-151.76%0.2M11.1M49.81K
2026-06-301.63%0.2M10.7M49.81K
2026-06-151.90%0.2M9.7M55.25K
2026-05-292.40%0.2M9.7M52.91K
2026-05-155.60%0.5M8.9M48.61K
2026-04-303.04%0.3M9.4M35.40K
2026-04-152.63%0.2M9.4M42.17K
2026-03-312.41%0.2M9.9M41.49K
2026-03-131.72%0.2M9.8M30.67K
2026-02-271.80%0.2M9.8M23.89K
2026-02-131.74%0.2M9.8M25.24K
2026-01-301.97%0.2M9.8M25.40K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-09-22S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-318-KCurrent report2026-08-28SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-08-188-KCurrent report2026-08-18SEC
2026-08-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-128-KCurrent report2026-08-12SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-063Initial statement of beneficial ownership of securities2026-07-28SEC
2026-08-03S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-288-KCurrent report2026-07-28SEC
2026-07-02DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-07-02SEC
2026-06-22PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-22SEC
2026-05-218-KCurrent report2026-05-15SEC
2026-05-15424B5SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-05-08SCHEDULE 13G/ASEC
2026-04-03EFFECTEffectiveness filing by commission orderSEC
2026-04-01CORRESPSEC
2026-03-31EFFECTEffectiveness filing by commission orderSEC
2026-03-31EFFECTEffectiveness filing by commission orderSEC
2026-03-31EFFECTEffectiveness filing by commission orderSEC
2026-03-31UPLOADUpload SubmissionSEC
2026-03-27S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-03-258-KCurrent report2026-03-20SEC
2026-03-25POS AMPost-effective amendment to a registration statement that is not immediately effective upon filingSEC
2026-03-25POS AMPost-effective amendment to a registration statement that is not immediately effective upon filingSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Lynrock Lake LP8.08%
Alyeska Investment Group, L.P.5.10%
VANGUARD CAPITAL MANAGEMENT LLC2.59%
Bleichroeder LP2.30%
GEODE CAPITAL MANAGEMENT, LLC0.93%
CITADEL ADVISORS LLC0.83%
Stonepine Capital Management, LLC0.73%
PERKINS CAPITAL MANAGEMENT INC0.68%
BlackRock, Inc.0.45%
MILLENNIUM MANAGEMENT LLC0.40%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.79%
VANGUARD EXTENDED MARKET INDEX FUND0.75%
Fidelity Extended Market Index Fund0.32%
Fidelity Total Market Index Fund0.25%
iShares Micro-Cap ETF0.23%
Fidelity Series Total Market Index Fund0.15%
Fidelity Nasdaq Composite Index Fund0.06%
VANGUARD BALANCED INDEX FUND0.04%
1290 VT Micro Cap Portfolio0.01%

OakChart. QTI. Cached 15 minutes.

Some panels did not load: ratings.